ClinicalTrials.govpublic full text
Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
gastric cancer, stomach neoplasms, chemotherapy, adjuvant, oxaliplatin, capecitabine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 875190
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.